Jatinder Kaur Mukker

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Randomized Controlled Trial

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Timothy Anthony Yap, Anthony W Tolcher, Ruth Plummer, Jatinder Kaur Mukker, Marta Enderlin, Christine Hicking, Thomas Grombacher, Giuseppe Locatelli, Zoltan Szucs, Ioannis Gounaris, Johann S de Bono
First-in-Human Study of the Ataxia Telangiectasia and Rad3-Related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Timothy Anthony Yap, Anthony W Tolcher, Ruth Plummer, Jatinder Kaur Mukker, Marta Enderlin, Christine Hicking, Thomas Grombacher, Giuseppe Locatelli, Zoltan Szucs, Ioannis Gounaris, Johann S de Bono
First-in-Human Study of the Ataxia Telangiectasia and Rad3-Related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Timothy Anthony Yap, Anthony W Tolcher, Ruth Plummer, Jatinder Kaur Mukker, Marta Enderlin, Christine Hicking, Thomas Grombacher, Giuseppe Locatelli, Zoltan Szucs, Ioannis Gounaris, Johann S de Bono
First-in-Human Study of the Ataxia Telangiectasia and Rad3-related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Timothy Anthony Yap, Anthony W Tolcher, Ruth Plummer, Jatinder Kaur Mukker, Marta Enderlin, Christine Hicking, Thomas Grombacher, Giuseppe Locatelli, Zoltan Szucs, Ioannis Gounaris, Johann S de Bono
First-in-Human Study of the Ataxia Telangiectasia and Rad3-Related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Aarti Sawant-Basak, Shweta Urva, Jatinder Kaur Mukker, Sebastian Haertter, Dean Mariano, Dolly A Parasrampuria, Kosalaram Goteti, Ravi Shankar Prasad Singh, Manoj S Chiney, Michael Z Liao, Sandy S Chang, Rashmi Mehta
Role of Clinical Pharmacology in Diversity and Inclusion in Global Drug Development: Current Practices and Industry Perspectives: White Paper. Clinical pharmacology and therapeutics (2024)
Timothy Anthony Yap, Anthony W Tolcher, Ruth Plummer, Jatinder Kaur Mukker, Marta Enderlin, Christine Hicking, Thomas Grombacher, Giuseppe Locatelli, Zoltan Szucs, Ioannis Gounaris, Johann S de Bono
First-in-Human Study of the Ataxia Telangiectasia and Rad3-Related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)